Role of Home-based Transcutaneous Electrical Acustimulation for Treatment of Pain in Patients With Chronic Pancreatitis

Inclusion Criteria: * Diagnosis of chronic pancreatitis (CP), based on a score greater or equal to 4 using a previously validated Mayo scoring system that uses morphologic and functional criteria, or endosonographic features suggestive or consistent with CP based on Rosemont criteria. * Abdominal pain present at least once within the last month * Willing and able to provide written informed consent Exclusion Criteria: * Pregnancy or breastfeeding mother * Imprisoned individuals * Non-English speaking patients * Scheduled for or with a history of pancreatic surgery (e.g. Total Pancreatectomy with Islet Auto Transplantation (TPIAT), Puestow, Frey, Whipple, other) * Currently undergoing or about to start endoscopic therapy with Endoscopic retrograde cholangiopancreatography (ERCP) or Endoscopic ultrasound (EUS) * Recent history of acute pancreatitis as defined by the Revised Atlanta Classification within a month prior to enrollment * Radiologic and clinical findings consistent with symptomatic pseudocyst, wall-off necrosis, infected pancreatic necrosis, or biliary obstruction within the last 6 months * Self-reported daily use of opioids for \> 12 months for weak opioids (codeine, tramadol and hydrocodone) or \> 6 months for strong opioids (other opioids) in the last two years. -Self-reported ongoing illicit drug use or abuse- * Suspected or diagnosed pancreatic cancer * Receiving chemotherapy for cancer * Known allergy to adhesive electrocardiogram (ECG) electrodes * Patients with bilateral below the knee amputation * Patients with lower extremity paralysis * Patient is participating in another clinical trial * Patients with an implantable electrical stimulation device.